# Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis

> **NCT00167921** · PHASE1 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 24 (—)

## Conditions studied

- Atrophic Vaginitis

## Interventions

- **DRUG:** Premarin® Vaginal Cream
- **DRUG:** Premarin® oral tablets

## Key facts

- **NCT ID:** NCT00167921
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 24 (—)
- **Last updated:** 2007-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00167921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00167921, "Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00167921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*